1. Korean Neurological Association. Textbook of Neurology. 2nd ed. Seoul: Panmun Education;2012. p. 548–52.
2. Khetsuriani N, Holman RC, Lamonte-Fowlkes AC, Selik RM, Anderson LJ. Trends in encephalitis-associated deaths in the United States. Epidemiol Infect. 2007; 135:583–91.

3. Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychol Rehabil. 2007; 17:406–28.

4. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006; 71:141–8.

5. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010; 17:999–e57.

6. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2005; 12:331–43.

7. DeBiasi RL, Tyler KL. Viral meningitis and encephalitis. Continuum: Lifelong Learning in Neurology. 2006; 12:58–94.

8. Lee KW. Textbook of Neurology. 2nd ed. Seoul: Panmun Education;2005. p. 430–7.
9. Aslanzadeh J. Preventing PCR amplification carryover contamination in a clinical laboratory. Ann Clin Lab Sci. 2004; 34:389–96.
10. Kim OJ. Acute Viral Encehalitis. J Neurocrit Care. 2008; 1 Suppl 1:S69–S77.
11. Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA Jr. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982; 145:829–36.

12. Whitley RJ, Soong SJ, Linneman C Jr, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982; 247:317–20.

13. Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006; 43:1565–77.

14. Aslanzadeh J, Garner JG, Feder HM, Ryan RW. Use of polymerase chain reaction for laboratory diagnosis of herpes simplex virus encephalitis. Ann Clin Lab Sci. 1993; 23:196–202.
15. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. 2002; 34:1154–7.

16. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995; 171:857–63.
17. Kamei S, Takasu T, Morishima T, Yoshihara T, Tetsuka T. Comparative study between chemiluminescence assay and two different sensitive polymerase chain reactions on the diagnosis of serial herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry. 1999; 67:596–601.

18. Sawlani V. Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis. J Neurol Sci. 2009; 287:221–6.

19. Tajima Y, Isonishi K, Kashiwaba T, Tashiro K. [Serial MRI, SPECT and 1H-MRS findings in a case of herpes simplex encephalitis]. No To Shinkei. 1998; 50:1023–7.
20. Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986; 314:144–9.

21. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012; 64:347–73.
22. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovirinduced renal failure. Clinical course and histology. Am J Med. 1988; 84:1067–71.
23. Yan HJ. Herpes simplex encephalitis: the role of surgical decompression. Surg Neurol. 2002; 57:20–4.

24. Hackanson B, Zeiser R, Bley TA, Pantazis G, Huzly D, Bertz H, et al. Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2005; 19:566–70.

25. De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP, steering c, et al. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect. 2012; 18:808–19.

26. Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology. 2008; 70:853–60.

27. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009; 8:731–40.

28. Persson A, Bergstrom T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol. 2009; 46:249–53.

29. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007; 68:1069–73.

30. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med. 1996; 125:577–87.

31. Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes: the journal of the IHMF. 2004; 11:95A–104A.
32. Bhanushali MJ, Kranick SM, Freeman AF, Cuellar-Rodriguez JM, Battiwalla M, Gea-Banacloche JC, et al. Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology. 2013; 80:1494–500.

33. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010; 9:1097–105.

34. Kim KW, Ahn SW, Park KY, Youn YC, Shin HW. Enteroviral encephalitis presenting as rapidly progressive aphasia. J Neurol Sci. 2012; 319:156–7.

35. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. 2006; 50:2409–14.

36. Turtle L, Griffiths MJ, Solomon T. Encephalitis caused by flaviviruses. QJM. 2012; 105:219–23.

37. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet. 2008; 371:500–9.

38. Centers for Disease C, Prevention. West nile virus disease and other arboviral diseases - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012; 61:510–4.
39. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003; 290:511–5.

40. Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001; 344:1807–14.

41. Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci. 2004; 31:185–93.

42. Brilla R, Block M, Geremia G, Wichter M. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci. 2004; 220:37–40.

43. Handique SK. Viral infections of the central nervous system. Neuroimaging Clin N Am. 2011; 21:777–94. vii.
44. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011; 89:766–74. 74A-74E.
45. Kalita J, Das BK, Misra UK. SPECT studies of regional cerebral blood flow in 8 patients with Japanese encephalitis in subacute and chronic stage. Acta Neurol Scand. 1999; 99:213–8.

46. Dutta K, Nazmi A, Basu A. Chemotherapy in Japanese encephalitis: are we there yet? Infect Disord Drug Targets. 2011; 11:300–14.

47. Dutta P, Khan SA, Khan AM, Borah J, Sarmah CK, Mahanta J. The effect of insecticide-treated mosquito nets (ITMNs) on Japanese encephalitis virus seroconversion in pigs and humans. Am J Trop Med Hyg. 2011; 84:466–72.

48. Ekstrand JJ, Herbener A, Rawlings J, Turney B, Ampofo K, Korgenski EK, et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol. 2010; 68:762–6.

49. Surana P, Tang S, McDougall M, Tong CY, Menson E, Lim M. Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review. Eur J Pediatr. 2011; 170:1007–15.

50. Glaser CA, Winter K, DuBray K, Harriman K, Uyeki TM, Sejvar J, et al. A population-based study of neurologic manifestations of severe influenza A (H1N1) pdm09 in California. Clinical Infectious Diseases. 2012; 55:514–20.
51. Yoshikawa H, Yamazaki S, Watanabe T, Abe T. Study of influenza-associated encephalitis/encephalopathy in children during the 1997 to 2001 influenza seasons. J Child Neurol. 2001; 16:885–90.

52. Sonneville R, Klein I, de Broucker T, Wolff M. Post-infectious encephalitis in adults: diagnosis and management. J Infect. 2009; 58:321–8.

53. Kuperan S, Ostrow P, Landi MK, Bakshi R. Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings. Neurology. 2003; 60:721–2.

54. Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, et al. Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome. Brain. 2003; 126:2279–90.

55. Sonneville R, Demeret S, Klein I, Bouadma L, Mourvillier B, Audibert J, et al. Acute disseminated encephalomyelitisin the intensive care unit: clinical features and outcome of 20 adults. Intensive Care Medicine. 2008; 34:528–32.
56. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 2000; 54:1370–2.

57. Khurana DS, Melvin JJ, Kothare SV, Valencia I, Hardison HH, Yum S, et al. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics. 2005; 116:431–6.

58. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008; 47:303–27.
